Educational content only. Not medical advice. GHK-Cu, KPV, and MOTS-c are research peptides — regulatory status varies. Injectable use should be explored with a qualified provider familiar with peptide protocols. Always verify source quality.
Three peptides. Remarkable results.
Peptides are short chains of amino acids — the same building blocks your skin already uses to repair and rebuild itself. Think of them as targeted signals that tell your skin cells to do specific jobs. These three have different mechanisms and are deeply complementary.
A naturally occurring copper peptide your body already makes — levels decline with age. Acts as a master repair signal, turning on genes responsible for collagen, elastin, and skin regeneration. One of the most studied cosmetic peptides in the world.
Derived from your body's own anti-inflammatory hormone (α-MSH). One targeted job: turn off the inflammatory signals causing redness, irritation, and skin breakdown. No pigmentation side effects. Well-tolerated across skin types. Orally active — unusual for peptides.
Encoded in mitochondrial DNA — not nuclear DNA like most peptides. A 16-amino acid signal released during metabolic stress. Activates AMPK, the body's master energy switch, driving glucose metabolism, fat oxidation, and cellular repair from the inside out. Levels decline with age.
The body's master antioxidant — a tripeptide your cells produce naturally to neutralize free radicals and regulate melanin production. Levels decline with age and oxidative stress. Oral and topical forms have solid RCT evidence for skin brightening, hyperpigmentation, and barrier support. IV is a different story — see the honest note below.
Social media has pushed IV glutathione hard. The research hasn't kept up with the hype. Multiple systematic reviews flag IV glutathione as contraindicated for cosmetic use — with documented cases of liver failure, kidney failure, anaphylaxis, and Stevens-Johnson syndrome. IV is not FDA approved for any skin indication. The evidence-supported routes are oral and topical. If someone is offering you IV glutathione at a spa or wellness clinic for skin brightening, that's a red flag worth taking seriously.
Four ways to deliver the goods.
Each method reaches the skin differently. Results build when you layer them thoughtfully.
Serums and creams applied directly to skin. GHK-Cu gives a slightly blue-tinted serum. Results are gradual but real with consistent use. GHK-Cu 0.05–0.1% serum nightly. KPV 0.1–1% cream twice daily on problem areas. Avoid mixing with strong acids same application.
Hydrolyzed collagen peptides (10–15g daily) + Vitamin C for synthesis. KPV orally active (10–20mg daily). Oral glutathione 250–500mg daily — RCT evidence for melanin reduction and skin brightening; combine with topical for superior results. Oral routes may outperform topical for overall tone.
Micro-channels allow peptides to reach the dermis where topical application can't go. Apply GHK-Cu serum within 15 minutes of needling — channels close quickly. Professional devices (1–1.5mm) superior to home rollers. 2024 study: 25% faster recovery, 30% lower inflammation markers. Space sessions 4–8 weeks apart.
Subcutaneous injection delivers peptides below the skin — bypassing all penetration barriers. GHK-Cu: 2mg in 2mL bacteriostatic saline, 32G needle. KPV subQ: 200–500mcg daily for systemic inflammatory concerns. MOTS-c: 5–10mg, 2–3x per week, 8–12 weeks on / 4 weeks off. Work with a knowledgeable provider.
How to stack it.
For real, compounding results — especially if skin laxity, texture, or post-weight-change skin is a concern. Each layer amplifies the next.
Oral collagen peptides (10–15g) + Vitamin C. Systemic support that feeds your skin from below. Non-negotiable foundation for the whole stack.
GHK-Cu serum (0.05–0.1%) on clean skin. Alternate nights with KPV cream if redness or sensitivity is a concern.
Professional device at 1–1.5mm, followed immediately by GHK-Cu serum in the 15-minute absorption window. This is your heavy hitter for collagen remodeling.
GHK-Cu mesotherapy 2x/month between needling sessions. Add KPV subQ if systemic inflammation is a factor.
SubQ 5–10mg, 2–3x per week. Particularly valuable for GLP-1 users — improves insulin sensitivity, drives fat oxidation, and supports the cellular energy that translates to skin vitality. Cycle 8–12 weeks on / 4 weeks off.
GLOW vs. KLOW — choosing your protocol.
Three options, different missions. Start with the Skin-Only stack if you're new to peptides or want pure skin results without the complexity. Add BPC-157 and TB-500 when you want systemic repair and recovery in the mix.
The original regenerative trio. BPC-157 drives cellular repair and angiogenesis. TB-500 enhances tissue remodeling and cell migration. GHK-Cu handles collagen signaling and skin rejuvenation. Your beauty and recovery stack.
- Pure cosmetic goals — firming, texture, glow
- Post-surgical or post-procedure recovery
- Sports injuries, joint and tendon repair
- No significant systemic inflammatory burden
The simplified skin-first option. GHK-Cu rebuilds collagen and triggers repair signaling. KPV calms inflammation and protects the barrier. No BPC-157, no TB-500 — no tissue repair or joint compounds in the mix. Pure skin biology, lower complexity, lower cost, easier to source.
- Skin collagen + glow goals without systemic repair
- New to peptides — best entry point for skin use
- GLP-1 users who want skin support without a full stack
- Budget-conscious: fewer compounds, lower monthly cost
GLOW with one powerful addition: KPV. That single peptide redirects the stack's biological focus toward immune modulation — calming chronic inflammation that keeps undermining repair. Shield and build.
- Inflammatory skin conditions (eczema, rosacea, psoriasis)
- GLP-1 users experiencing skin laxity or gut-skin disruption
- Post-antibiotic or high-stress recovery phases
- Anyone with systemic inflammation alongside skin concerns
"These peptides work by reminding your biology how to heal — not overriding it. The off-cycle is where your body consolidates the gains."
If you're on a GLP-1 journey.
Rapid fat loss reduces inflammation long-term but can cause short-term skin laxity, texture changes, and barrier disruption. This is exactly where KLOW paired with a GLP-1 protocol becomes a logical combination: the GLP-1 handles the metabolic work; KLOW handles repair, barrier support, and inflammation control at the skin level simultaneously.
Triple agonist. Extraordinary early data.
Currently in Phase 3 clinical trials. Not FDA approved. Cannot be legally compounded. Presented here as research context only.
~20% LDL reduction, ~40% triglyceride reduction, blood pressure improvement. Glucagon agonism may lower PCSK9 independently of weight loss.
72% of prediabetic participants reverted to normal blood sugar in Phase 2 NEJM trial. Significant insulin resistance improvement across all dose groups.
TRIUMPH-4: 75.8% reduction in knee osteoarthritis pain scores. More than 1 in 8 participants completely free from knee pain at 68 weeks.
Glossary of terms.
Naturally occurring tripeptide (Glycine-Histidine-Lysine) bound to copper. Activates genes for collagen, elastin, and skin matrix repair. The most extensively studied cosmetic peptide, with clinical evidence for firming, wound healing, and post-procedure recovery.
Tripeptide from α-MSH. Anti-inflammatory via NF-κB and MAPK pathway inhibition. No pigmentation changes. Effective for redness, rosacea, eczema, acne, and barrier repair. Can be delivered topically, orally, or via subcutaneous injection.
16-amino acid peptide encoded by mitochondrial DNA. Acts as a "mitochondrial hormone," traveling to the cell nucleus during metabolic stress. Activates AMPK. Levels decline with age. Most evidence currently from animal models and early human studies.
The body's "master energy switch." Activated when cellular energy is low. Promotes glucose uptake, fat burning, and mitochondrial biogenesis. MOTS-c's primary mechanism. Also activated by metformin and caloric restriction.
Three-peptide combination for collagen synthesis, tissue repair, angiogenesis, and skin rejuvenation. Best for cosmetic skin goals, post-procedure recovery, and sports injury repair. Typical cycle: 6 weeks on, 2–4 off.
GLOW with KPV added. Redirects focus toward immune modulation. For GLP-1 users, autoimmune skin conditions, post-antibiotic recovery, or anyone with systemic inflammation alongside skin concerns. Typical cycle: 8 weeks on, 2–4 off.
Bidirectional relationship between gastrointestinal health and skin condition. Gut inflammation often manifests as skin redness, acne, or rosacea. KPV works on both simultaneously — particularly relevant for GLP-1 users experiencing gut-related side effects.
Injection into the fatty tissue layer just below the skin — not into muscle or vein. Standard delivery for GHK-Cu, KPV, BPC-157, TB-500, and MOTS-c injectable protocols. Use 29–32 gauge needle. Abdomen, thigh, or upper arm.
A naturally occurring tripeptide (glutamine-cysteine-glycine) and the body's primary intracellular antioxidant. Inhibits tyrosinase — the enzyme that produces melanin — through direct antioxidant activity and copper chelation. Oral (250–500mg daily) and topical (0.5–2%) forms have RCT evidence for skin brightening and hyperpigmentation. IV form carries serious documented risks and is not supported by evidence for skin use.
GHK-Cu rebuilds collagen. KPV calms inflammation. MOTS-c drives cellular energy. Glutathione brightens, defends against oxidative stress, and evens tone. Three stacks to choose from: Skin-Only (GHK-Cu + KPV) for pure skin goals or beginners; GLOW (+ BPC-157 + TB-500) for repair + recovery; KLOW (+ all four) for repair + inflammation, GLP-1 users, and gut-skin disruption. MOTS-c adds on top for cellular energy. Glutathione: oral and topical have good RCT evidence — IV is contraindicated, carry real risks. Research peptides — not FDA approved as drugs. Source quality matters. Work with a provider when going injectable.